Dr John Xiaojiang Hu, MD, PHD | |
Po Box 2728, Florence, AZ 85132-3051 | |
(520) 866-7275 | |
Not Available |
Full Name | Dr John Xiaojiang Hu |
---|---|
Gender | Male |
Speciality | Pathology - Forensic Pathology |
Location | Po Box 2728, Florence, Arizona |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801307715 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZF0201X | Pathology - Forensic Pathology | 28529 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Xiaojiang Hu, MD, PHD 570 West Adamsville Road, P. O. Box 2728, Florence, AZ 85132 Ph: (520) 866-7275 | Dr John Xiaojiang Hu, MD, PHD Po Box 2728, Florence, AZ 85132-3051 Ph: (520) 866-7275 |
News Archive
Researchers at Washington University in St. Louis have developed algorithms to identify weak spots in tendons, muscles and bones prone to tearing or breaking.
The U.S. Food and Drug Administration (FDA) has approved maraviroc, an antiretroviral drug for use in adult HIV patients. Maraviroc, sold under the trade name Selzentry, is the first in a new class of drugs designed to slow the advancement of HIV and received priority review by the FDA.
My colleagues Margot Sanger-Katz and Amanda Cox wrote recently that shopping around for the best price can be crucial for people renewing their coverage on the health insurance exchanges this fall.
A treatment program that stresses maintaining a regular schedule of daily activities and stability in personal relationships is an effective therapy for bipolar disorder, report University of Pittsburgh School of Medicine researchers in September's Archives of General Psychiatry.
The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online today in Blood, the Journal of the American Society of Hematology (ASH).
› Verified 7 days ago